Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help identify patients with lung cancer, but do not differentiate between lung cancer subtypes.
about
Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis.Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios may aid in identifying patients with non-small cell lung cancer and predicting Tumor-Node-Metastasis stages.Q58736041
P2860
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help identify patients with lung cancer, but do not differentiate between lung cancer subtypes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neutrophil-to-lymphocyte and p ...... between lung cancer subtypes.
@en
Neutrophil-to-lymphocyte and p ...... between lung cancer subtypes.
@nl
type
label
Neutrophil-to-lymphocyte and p ...... between lung cancer subtypes.
@en
Neutrophil-to-lymphocyte and p ...... between lung cancer subtypes.
@nl
prefLabel
Neutrophil-to-lymphocyte and p ...... between lung cancer subtypes.
@en
Neutrophil-to-lymphocyte and p ...... between lung cancer subtypes.
@nl
P2093
P2860
P356
P1476
Neutrophil-to-lymphocyte and p ...... between lung cancer subtypes.
@en
P2093
Biserka Orehovec
Dominik Romić
Ida Taradi
Igor Nikolić
Leonardo Patrlj
Marko Žarak
Miroslav Samaržija
Suzana Kukulj
Toni Kolak
Vjekoslav Jeleč
P2860
P304
P356
10.3325/CMJ.2016.57.287
P577
2016-06-01T00:00:00Z